Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,011,980
-
Share change
-
+25,339
-
Total reported value
-
$198,628,232
-
Price per share
-
$49.51
-
Number of holders
-
89
-
Value change
-
+$820,999
-
Number of buys
-
40
-
Number of sells
-
39
Institutional Holders of BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) as of Q2 2017
As of 30 Jun 2017,
BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,011,980 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, EAGLE ASSET MANAGEMENT INC, ACADIAN ASSET MANAGEMENT LLC, RICE HALL JAMES & ASSOCIATES, LLC, Elk Creek Partners, LLC, GOLDMAN SACHS GROUP INC, and NORTHPOINTE CAPITAL LLC.
This page lists
89
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.